Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Korean Med Sci ; 30(5): 576-85, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-25931788

RESUMO

Pulmonary arterial hypertension (PAH) causes right ventricular failure due to a gradual increase in pulmonary vascular resistance. The purposes of this study were to confirm the engraftment of human umbilical cord blood-mesenchymal stem cells (hUCB-MSCs) placed in the correct place in the lung and research on changes of hemodynamics, pulmonary pathology, immunomodulation and several gene expressions in monocrotaline (MCT)-induced PAH rat models after hUCB-MSCs transfusion. The rats were grouped as follows: the control (C) group; the M group (MCT 60 mg/kg); the U group (hUCB-MSCs transfusion). They received transfusions via the external jugular vein a week after MCT injection. The mean right ventricular pressure (RVP) was significantly reduced in the U group after the 2 week. The indicators of RV hypertrophy were significantly reduced in the U group at week 4. Reduced medial wall thickness in the pulmonary arteriole was noted in the U group at week 4. Reduced number of intra-acinar muscular pulmonary arteries was observed in the U group after 2 week. Protein expressions such as endothelin (ET)-1, endothelin receptor A (ERA), endothelial nitric oxide synthase (eNOS) and matrix metalloproteinase (MMP)-2 significantly decreased at week 4. The decreased levels of ERA, eNOS and MMP-2 immunoreactivity were noted by immnohistochemical staining. After hUCB-MSCs were administered, there were the improvement of RVH and mean RVP. Reductions in several protein expressions and immunomodulation were also detected. It is suggested that hUCB-MSCs may be a promising therapeutic option for PAH.


Assuntos
Sangue Fetal/citologia , Hipertensão Pulmonar/terapia , Transplante de Células-Tronco Mesenquimais , Células-Tronco Mesenquimais/citologia , Animais , Citocinas/metabolismo , Modelos Animais de Doenças , Endotelina-1/metabolismo , Regulação da Expressão Gênica/efeitos dos fármacos , Hemodinâmica , Humanos , Hipertensão Pulmonar/induzido quimicamente , Hipertrofia Ventricular Direita/fisiopatologia , Imuno-Histoquímica , Pulmão/metabolismo , Pulmão/patologia , Masculino , Metaloproteinase 2 da Matriz/metabolismo , Células-Tronco Mesenquimais/metabolismo , Monocrotalina/toxicidade , Óxido Nítrico Sintase Tipo III/metabolismo , Artéria Pulmonar/patologia , Ratos , Ratos Sprague-Dawley , Receptor de Endotelina A/metabolismo
2.
J Biomed Opt ; 18(8): 80502, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23922122

RESUMO

A combined two-photon microscopy (TPM) and angiographic optical coherence tomography (OCT) is developed, which can provide molecular, cellular, structural, and vascular information of tissue specimens in vivo. This combined system is implemented by adding an OCT vasculature visualization method to the previous combined TPM and OCT, and then is applied to in vivo tissue imaging. Two animal models, a mouse brain cranial window model and a mouse ear cancer model, are used. Both molecular, cellular information at local regions of tissues, and structural, vascular information at relatively larger regions are visualized in the same sections. In vivo tissue microenvironments are better elucidated by the combined TPM and angiographic OCT.


Assuntos
Angiografia/métodos , Neoplasias da Orelha/irrigação sanguínea , Neoplasias da Orelha/patologia , Microscopia de Fluorescência por Excitação Multifotônica/métodos , Imagem Multimodal/métodos , Neovascularização Patológica/patologia , Tomografia de Coerência Óptica/métodos , Animais , Linhagem Celular Tumoral , Neoplasias da Orelha/complicações , Interpretação de Imagem Assistida por Computador/métodos , Camundongos , Neovascularização Patológica/complicações , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Técnica de Subtração
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA